Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267964; DOI: https://doi.org/10.2967/jnumed.124.267964 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267736; DOI: https://doi.org/10.2967/jnumed.124.267736 ...
Journal of Nuclear Medicine September 2024, jnumed.123.267215; DOI: https://doi.org/10.2967/jnumed.123.267215 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267578; DOI: https://doi.org/10.2967/jnumed.124.267578 ...
Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?
No CN patients had thrombocytopenia of > grade 4 while 5.8% of MAP patients had thrombocytopenia of >grade 4 (table1). 11.7% MAP patients had anemia of >grade 4, whereas 11.1 % CN patients developed ...
Objectives Primary and metastatic bone cancer are significant sources of morbidity and mortality in cancer patients. Available treatments include bisphosphonates, anti-inflammatory and opioid pain ...
Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...